Aquestive Therapeutics
Clinical trials sponsored by Aquestive Therapeutics, explained in plain language.
A pharmaceutical company developing oral film-based medications.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedThis study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is t…
Phase 1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
No-Needle epinephrine: could a dissolving film replace the shot?
Disease control CompletedThis Phase 2 study tested a new dissolvable film called DESF that delivers epinephrine under the tongue. Thirty-six healthy adults with oral allergy syndrome received DESF and standard epinephrine injections to compare how quickly the drug enters the bloodstream. The goal is to s…
Phase 2 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC